E-mail

E-mail a Wiley Online Library Link

Michael T. Schweizer, Peng Huang, Michael W. Kattan, Adam S. Kibel, Ronald de Wit, Cora N. Sternberg, Jonathan I. Epstein and Mario A. Eisenberger Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501) Cancer 119

Version of Record online: 13 AUG 2013 | DOI: 10.1002/cncr.28270

The role of adjuvant systemic therapy after radical prostatectomy in patients with prostate cancer remains unclear. Trials in these patients are difficult for a multitude of reasons.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH